Related Experiment Video
Updated: Nov 27, 2025
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
8.5K
Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates
Daniel Wong1, Javier Rincon1, Grant Henning1
1Washington University in Saint Louis School of Medicine, Saint Louis, MO.
Urology
|December 6, 2020
Summary
Retzius sparing prostatectomy significantly increases the risk of symptomatic lymphoceles, often requiring intervention. This approach may impair lymph reabsorption, necessitating careful consideration in surgical planning.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Robot-assisted radical prostatectomy (RARP) is a standard treatment for prostate cancer.
- The Retzius-sparing approach aims to preserve neurovascular structures but its impact on lymphatic complications is under investigation.
Purpose of the Study:
- To compare the incidence of symptomatic lymphoceles between standard and Retzius-sparing RARP.
- To identify risk factors associated with lymphocele formation after RARP.
Main Methods:
- Retrospective review of 81 robot-assisted laparoscopic prostatectomies performed by two surgeons.
- Patients were categorized into standard (n=31) and Retzius-sparing (n=50) groups.
- Symptomatic lymphoceles were diagnosed based on clinical presentation and confirmed by CT scan.
Main Results:
- The Retzius-sparing group had a significantly higher rate of symptomatic lymphoceles (18%) compared to the standard group (0%).
- Retzius sparing prostatectomy was a strong predictor of lymphocele occurrence (OR 23.77).
- Lymph node yield was higher in the Retzius-sparing group.
Conclusions:
- Retzius sparing prostatectomy is a significant predictor of symptomatic lymphocele development.
- Impaired lymph reabsorption due to approximated peritoneal lining may contribute to lymphocele formation.
- Most lymphoceles in the Retzius-sparing group required intervention, such as IR drainage and antibiotics.
